Tags
#Zcash
Winklevoss Files for Zcash Spot ETF Under Ticker WINK, Custody Handled by Gemini
Winklevoss Asset Services has officially filed for a Zcash spot ETF under the ticker WINK, with custody handled by its own exchange Gemini and a management fee set at 0.25%, putting it in direct competition with Grayscale's existing ZCSH.
Bitcoin returns to US$80,000, Zcash leads the rally, the total market value of the crypto market reaches US$2.82 trillion
Bitcoin reached the US$80,000 mark, driving the total market value of cryptocurrencies to US$2.82 trillion. The privacy coin Zcash performed most prominently in this wave of gains. Related stocks such as Strategy rose simultaneously, but the market still has different views on the path of the Federal Reserve's interest rates.
Grayscale Launches First Zcash ETF, Privacy Coin Officially Enters Traditional Market Tools
Grayscale launched the first ETF to directly hold Zcash on Tuesday morning, marking the first time a privacy-focused cryptocurrency has entered the traditional market in this form, with the timing coinciding with a rise in Zcash's price.
Zcash Surges to 8-Year High, Nears $850 as 24-Hour Futures Volume Hits Nearly $10 Billion
Zcash's price touched an eight-year high, nearing $850, but 24-hour futures trading volume during the same period reached almost $10 billion—far outpacing the $1.76 billion in open interest, suggesting this rally is being driven by the derivatives market.
Grayscale Files Another Amendment, Countdown Begins for First US Zcash ETF
Grayscale submitted a new amended filing to the US Securities and Exchange Commission on Friday, paving the way for its planned Zcash ETF. If approved, it would be the first exchange-traded fund tracking Zcash in the US market.
Cypherpunk Mining Goes Live with Zcash Hashrate, The Block Says Winklevoss Poured in $33 Million
Cypherpunk Mining officially went live in the US today with roughly 4.2 GSol/s of Equihash hashrate targeting Zcash mining; a report from The Block says the buildout involves $33 million in funding tied to Winklevoss.